DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts DMAC Hot Sheet
Join SI Premium – FREE
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q3 EPS of ($0.17), in-line with the analyst estimate of ($0.17).
For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tradeweb Markets (TW) PT Lowered to $151 at Raymond James
- Popular stocks with increasing option volume: INTC MU SPCX RIVN PLTR NFLX NOK SOFI WMT NKE SNDK MRVL
- TRNR agrees to acquire STEPR, raises 2026 revenue guidance to $50M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
